Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Capital Leases (2018 - 2025)

Neurogene (NGNE) has disclosed Capital Leases for 5 consecutive years, with $7000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Leases fell 82.05% year-over-year to $7000.0, compared with a TTM value of $7000.0 through Sep 2025, down 82.05%, and an annual FY2024 reading of $26000.0, changed N/A over the prior year.
  • Capital Leases was $7000.0 for Q3 2025 at Neurogene, down from $9000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $53000.0 in Q1 2024 and bottomed at $7000.0 in Q3 2025.